Cancer is the second leading cause of death – globally, about 1 in 6 deaths is due to cancer. Low- and middle-income countries suffer from this problem the most with around 70% of deaths from cancer occurring there. This is largely due to late-stage presentation and generally inaccessible diagnosis and treatment in the public sector. The dramatic and increasing economic impact of cancer is estimated at more than US$ 1 trillion annually.
Cancer is actually not just one disease but more than 100 disease types, and each of these is divided into several sub-types. There is no unified cancer treatment available, and the reality is that scientists are looking for many cures for many types of cancer. It’s a slow, step-by-step process that requires collecting and analyzing information from laboratory research. Also, clinical trials take years before any new cancer treatment or cancer test become available on the market and/or in clinic use.
World Cancer Day 2020 (February 4, 2020) marks the midway point of the 3-year ‘I Am and I Will’ campaign, an empowering call-to-action urging for personal commitment and represents the power of individual action taken now to impact the future.
Let’s work together to reduce risk factors of cancer! Let’s do our best to make early diagnosis, treatment and palliative care better. Let’s unite our efforts to improve cancer control and achieve global targets to reduce premature mortality from cancer.
Supporting the World Cancer Day initiative, Life Chemicals presents a featured list of its cancer therapy-related products (Targeted and Focused Screening Libraries):
- Anticancer Screening Library
- CYP Inhibitors Focused Library
- Epigenetic Targeted and Focused Libraries
- GPCR Receptor-based Targeted Library
- Helicase Focused Library
- Ion Channels Focused Libraries
- Kinase Screening Libraries
- Matrix Metalloproteinase Focused Library
- Nuclear Receptors Targeted Library
- Phosphatase Focused Library
- Protein-Protein Interactions (PPI) Libraries
- Protease Screening Libraries
The Libraries are for HTS screening in cancer research projects as dry powders or DMSO solutions. Compound cherry-picking and customer-tailored selection is available.
For all queries on our products and their price quotations please contact us at: email@example.com. Please visit our website for more information and download sdf files with compound structures in the Downloads section.